LIVENT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.51 USD | -8.53% |
|
+140.60% | +120.93% |
| Apr. 09 | KeyBanc Trims Price Target on Arcadium Lithium to $11 From $12, Keeps Overweight Rating | MT |
| Apr. 04 | Raymond James Upgrades Arcadium Lithium to Strong Buy from Outperform | MT |
Evolution of the average Target Price on LIVENT
Price target over the last 5 years
History of analyst recommendation changes
a8dfdd00a63d23a2adb68d.tehpojGyyV-zk95OqX_QYx7tToQ__WY_LiERFNvaHhw.5KIb1XTBrWrsw_M-6A-2KHe_Hrddrz8PYlZzW-mTdi7woiDgc_e9cvrKrQ~de202959a75a743754a2e12f98942e0a
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
3.84
USD
Average target price
8.223
USD
Spread / Average Target
+114.15%
High Price Target
14
USD
Spread / Highest target
+264.58%
Low Price Target
5
USD
Spread / Lowest Target
+30.21%
Consensus detail
Consensus revision (last 18 months)
Analysts covering LIVENT
| KeyBanc Capital Markets | |
| Raymond James | |
| Piper Sandler | |
| Mizuho Securities | |
| JPMorgan Chase |
Trading Rating
Investor Rating
ESG Refinitiv
B+
EPS Revisions
- Stock Market
- Equities
- ALTM Stock
- LTHM Stock
- Consensus LIVENT
